Duopharma Biotech Bhd

XKLS:7148 (Malaysia)  
RM 1.16 (+0.87%) Apr 22
18.13
P/B:
1.65
Market Cap:
RM 1.12B ($ 233.45M)
Enterprise V:
RM 1.42B ($ 297.88M)
Volume:
174.90K
Avg Vol (2M):
346.85K
Volume:
174.90K
Avg Vol (2M):
346.85K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Duopharma Biotech Bhd ( XKLS:7148 ) from 2002 to Apr 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Duopharma Biotech Bhd stock (XKLS:7148) PE ratio as of Apr 23 2024 is 18.13. More Details

Duopharma Biotech Bhd (XKLS:7148) PE Ratio (TTM) Chart

To

Duopharma Biotech Bhd (XKLS:7148) PE Ratio (TTM) Historical Data

Total 1243
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Duopharma Biotech Bhd PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-23 18.1 2024-02-15 19.7
2024-04-22 18.1 2024-02-14 19.5
2024-04-19 18.0 2024-02-13 20.0
2024-04-18 18.1 2024-02-12 19.8
2024-04-17 17.8 2024-02-09 19.8
2024-04-16 18.1 2024-02-08 19.8
2024-04-15 18.3 2024-02-07 19.7
2024-04-12 18.4 2024-02-06 19.7
2024-04-09 18.8 2024-02-05 19.7
2024-04-08 18.6 2024-02-02 19.7
2024-04-05 18.8 2024-02-01 19.7
2024-04-04 18.9 2024-01-31 19.7
2024-04-03 18.9 2024-01-30 19.4
2024-04-02 19.1 2024-01-29 19.4
2024-04-01 18.9 2024-01-26 19.7
2024-03-29 18.8 2024-01-25 19.2
2024-03-27 18.8 2024-01-24 19.2
2024-03-26 18.9 2024-01-23 19.4
2024-03-25 18.8 2024-01-22 19.5
2024-03-22 19.1 2024-01-19 19.2
2024-03-21 18.9 2024-01-18 19.4
2024-03-20 18.8 2024-01-17 19.5
2024-03-19 18.8 2024-01-16 19.7
2024-03-18 18.6 2024-01-15 20.0
2024-03-15 18.9 2024-01-12 19.8
2024-03-14 18.6 2024-01-11 20.0
2024-03-13 18.6 2024-01-10 20.0
2024-03-12 18.4 2024-01-09 20.6
2024-03-11 18.4 2024-01-08 20.3
2024-03-08 18.4 2024-01-05 20.0
2024-03-07 18.3 2024-01-04 19.8
2024-03-06 18.6 2024-01-03 20.0
2024-03-05 18.6 2024-01-02 19.4
2024-03-04 18.6 2024-01-01 19.7
2024-03-01 18.9 2023-12-29 19.7
2024-02-29 19.1 2023-12-28 19.7
2024-02-28 18.8 2023-12-27 19.7
2024-02-27 18.8 2023-12-26 20.2
2024-02-26 18.6 2023-12-22 20.0
2024-02-23 18.6 2023-12-21 19.8
2024-02-22 18.9 2023-12-20 19.8
2024-02-21 19.1 2023-12-19 19.8
2024-02-20 19.4 2023-12-18 19.8
2024-02-19 19.4 2023-12-15 20.0
2024-02-16 19.7 2023-12-14 19.4

Duopharma Biotech Bhd (XKLS:7148) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer and exporter of pharmaceutical products and medicines.